Annual SGA
$4.66 M
-$3.61 M-43.67%
December 1, 2023
Summary
- As of February 8, 2025, KPRX annual SGA is $4.66 million, with the most recent change of -$3.61 million (-43.67%) on December 1, 2023.
- During the last 3 years, KPRX annual SGA has risen by +$4300.00 (+0.09%).
- KPRX annual SGA is now -43.67% below its all-time high of $8.28 million, reached on December 31, 2022.
Performance
KPRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.38 M
-$157.00 K-10.21%
September 1, 2024
Summary
- As of February 8, 2025, KPRX quarterly SGA is $1.38 million, with the most recent change of -$157.00 thousand (-10.21%) on September 1, 2024.
- Over the past year, KPRX quarterly SGA has dropped by -$34.80 thousand (-2.46%).
- KPRX quarterly SGA is now -50.29% below its all-time high of $2.78 million, reached on December 31, 2022.
Performance
KPRX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$555.40 M
+$5.55 M+0.99%
September 1, 2024
Summary
- As of February 8, 2025, KPRX TTM SGA is -$555.40 million, with the most recent change of +$5.55 million (+0.99%) on September 1, 2024.
- Over the past year, KPRX TTM SGA has dropped by -$561.97 million (-8565.76%).
- KPRX TTM SGA is now -908.21% below its all-time high of -$55.09 million.
Performance
KPRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
KPRX Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -43.7% | -2.5% | -8565.8% |
3 y3 years | +0.1% | +25.9% | -7837.4% |
5 y5 years | +5.0% | +25.9% | -7837.4% |
KPRX Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -43.7% | at low | -50.3% | +56.8% | -20.3% | +2.0% |
5 y | 5-year | -43.7% | +5.8% | -50.3% | +56.8% | -44.6% | +2.0% |
alltime | all time | -43.7% | +141.5% | -50.3% | +386.1% | -908.2% | +2.0% |
Kiora Pharmaceuticals Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $1.38 M(-10.2%) | $5.10 M(-0.7%) |
Jun 2024 | - | $1.54 M(+18.6%) | $5.13 M(+9.4%) |
Mar 2024 | - | $1.30 M(+47.2%) | $4.69 M(+0.6%) |
Dec 2023 | $4.66 M(-43.7%) | $880.60 K(-37.8%) | $4.66 M(-28.9%) |
Sep 2023 | - | $1.42 M(+29.0%) | $6.56 M(-8.6%) |
Jun 2023 | - | $1.10 M(-13.6%) | $7.18 M(-8.9%) |
Mar 2023 | - | $1.27 M(-54.3%) | $7.88 M(-4.8%) |
Dec 2022 | $8.28 M(+55.5%) | $2.78 M(+36.6%) | $8.28 M(+20.3%) |
Sep 2022 | - | $2.03 M(+12.8%) | $6.88 M(+11.2%) |
Jun 2022 | - | $1.80 M(+8.2%) | $6.18 M(+8.7%) |
Mar 2022 | - | $1.66 M(+20.7%) | $5.69 M(+6.9%) |
Dec 2021 | $5.32 M(+14.3%) | $1.38 M(+3.0%) | $5.32 M(-2.5%) |
Sep 2021 | - | $1.34 M(+2.5%) | $5.46 M(+6.2%) |
Jun 2021 | - | $1.31 M(+0.4%) | $5.14 M(+4.4%) |
Mar 2021 | - | $1.30 M(-14.2%) | $4.93 M(+5.7%) |
Dec 2020 | $4.66 M(+5.7%) | $1.51 M(+48.3%) | $4.66 M(+9.3%) |
Sep 2020 | - | $1.02 M(-6.3%) | $4.26 M(-0.6%) |
Jun 2020 | - | $1.09 M(+5.6%) | $4.29 M(-0.4%) |
Mar 2020 | - | $1.03 M(-7.7%) | $4.30 M(-2.3%) |
Dec 2019 | $4.41 M(-0.8%) | $1.12 M(+7.1%) | $4.41 M(+1.5%) |
Sep 2019 | - | $1.05 M(-5.5%) | $4.34 M(-4.1%) |
Jun 2019 | - | $1.11 M(-2.6%) | $4.53 M(-2.1%) |
Mar 2019 | - | $1.14 M(+8.0%) | $4.62 M(+4.1%) |
Dec 2018 | $4.44 M | $1.05 M(-14.6%) | $4.44 M(-1.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2018 | - | $1.23 M(+2.5%) | $4.48 M(+4.5%) |
Jun 2018 | - | $1.20 M(+26.0%) | $4.29 M(-0.2%) |
Mar 2018 | - | $954.00 K(-12.9%) | $4.30 M(-7.2%) |
Dec 2017 | $4.64 M(-17.1%) | $1.10 M(+5.5%) | $4.64 M(-3.9%) |
Sep 2017 | - | $1.04 M(-14.4%) | $4.82 M(-3.3%) |
Jun 2017 | - | $1.21 M(-5.9%) | $4.99 M(-6.8%) |
Mar 2017 | - | $1.29 M(+0.4%) | $5.35 M(-4.3%) |
Dec 2016 | $5.59 M(+41.2%) | $1.28 M(+6.8%) | $5.59 M(-0.1%) |
Sep 2016 | - | $1.20 M(-23.9%) | $5.60 M(+4.8%) |
Jun 2016 | - | $1.58 M(+3.3%) | $5.35 M(+13.6%) |
Mar 2016 | - | $1.53 M(+18.3%) | $4.71 M(+18.8%) |
Dec 2015 | $3.96 M(+105.1%) | $1.29 M(+36.5%) | $3.96 M(+34.1%) |
Sep 2015 | - | $946.20 K(+0.7%) | $2.95 M(+18.7%) |
Jun 2015 | - | $939.50 K(+20.0%) | $2.49 M(+20.9%) |
Mar 2015 | - | $782.80 K(+175.5%) | $2.06 M(+6.6%) |
Dec 2014 | $1.93 M(-7.5%) | $284.10 K(-40.9%) | $1.93 M(-10.2%) |
Sep 2014 | - | $480.40 K(-5.8%) | $2.15 M(-3.2%) |
Jun 2014 | - | $510.20 K(-22.2%) | $2.22 M(-4.2%) |
Mar 2014 | - | $656.20 K(+30.6%) | $2.32 M(+11.0%) |
Dec 2013 | $2.09 M(-25.9%) | $502.30 K(-8.8%) | $2.09 M(+31.7%) |
Sep 2013 | - | $550.80 K(-9.4%) | $1.59 M(+53.2%) |
Jun 2013 | - | $608.20 K(+42.6%) | $1.03 M(+142.6%) |
Mar 2013 | - | $426.40 K | $426.40 K |
Dec 2012 | $2.82 M | - | - |
FAQ
- What is Kiora Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals annual SGA year-on-year change?
- What is Kiora Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals quarterly SGA year-on-year change?
- What is Kiora Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals TTM SGA year-on-year change?
What is Kiora Pharmaceuticals annual SGA?
The current annual SGA of KPRX is $4.66 M
What is the all time high annual SGA for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high annual SGA is $8.28 M
What is Kiora Pharmaceuticals annual SGA year-on-year change?
Over the past year, KPRX annual SGA has changed by -$3.61 M (-43.67%)
What is Kiora Pharmaceuticals quarterly SGA?
The current quarterly SGA of KPRX is $1.38 M
What is the all time high quarterly SGA for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high quarterly SGA is $2.78 M
What is Kiora Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, KPRX quarterly SGA has changed by -$34.80 K (-2.46%)
What is Kiora Pharmaceuticals TTM SGA?
The current TTM SGA of KPRX is -$555.40 M
What is the all time high TTM SGA for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high TTM SGA is -$55.09 M
What is Kiora Pharmaceuticals TTM SGA year-on-year change?
Over the past year, KPRX TTM SGA has changed by -$561.97 M (-8565.76%)